Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Conclusion: For patients with LAC, ACT combined with CHMF after radical surgery can prolong the DFS time especially in the early stage, and reduces the chemotherapy-related toxic and side effects.
Trial Registration: NCT01441752. Registered 14 July, 2011.
PMID: 32140080 [PubMed]
Source: Biological Procedures Online - Category: Molecular Biology Authors: Wang Q, Jiao L, Wang S, Chen P, Bi L, Zhou D, Yao J, Li J, Wang L, Chen Z, Jia Y, Zhang Z, Shen W, Zhu W, Xu J, Gao Y, Xu L, Gong Y Tags: Biol Proced Online Source Type: research
More News: Adenocarcinoma | Chemotherapy | China Health | Complementary Medicine | Herbs | Molecular Biology | Statistics | Study | Thrombocytopenia | Toxicology